Literature DB >> 1940479

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.

A K Takala1, J Eskola, M Leinonen, H Käyhty, A Nissinen, E Pekkanen, P H Mäkelä.   

Abstract

The oropharyngeal carriage of Haemophilus influenzae type b (Hib) was studied among 725 healthy 3-year-old children who had or had not been immunized with an Hib conjugate vaccine. Oropharyngeal swabs were collected during the childrens' well-child visit to their local child health center. Fourteen (3.5%) of the 398 unvaccinated children were oropharyngeal carriers of Hib, whereas none of the 327 children who had received Hib conjugate vaccine carried Hib (P less than .001). Carriage rates of non-type b H. influenzae (19%) or Streptococcus pneumoniae (18%) were the same irrespective of the Hib vaccination status of the children. Thus Hib conjugate vaccine, unlike Hib polysaccharide vaccine, seems to be able to prevent oropharyngeal colonization by Hib.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940479     DOI: 10.1093/infdis/164.5.982

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  69 in total

Review 1.  New pneumococcal vaccines for children.

Authors:  S Choo; A Finn
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

2.  Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children.

Authors:  E V Millar; K L O'Brien; O S Levine; S Kvamme; R Reid; M Santosham
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

3.  Detection of meningococcal carriage by culture and PCR of throat swabs and mouth gargles.

Authors:  J Zoe Jordens; Jeannette N Williams; Graeme R Jones; John E Heckels
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 4.  Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.

Authors:  Q Zhang; A Finn
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

5.  Serological protection induced by Haemophilus influenzae Type B conjugate vaccine in Mexican children: is a booster dose of the vaccine needed?

Authors:  Romeo S Rodriguez; Cesar Mascarenas; Carlos J Conde-Glez; Jaime Inostroza; Sonia Villanueva; María Elena Velázquez; Miguel Angel Sánchez-Alemán; Gabriela Echániz
Journal:  Clin Vaccine Immunol       Date:  2010-08-18

Review 6.  Conjugate vaccines.

Authors:  A Finn; P Heath
Journal:  Arch Dis Child       Date:  2005-07       Impact factor: 3.791

7.  Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska.

Authors:  Henry C Baggett; Thomas W Hennessy; Lisa Bulkow; Sandra Romero-Steiner; Debra Hurlburt; Patricia Holder; Alan J Parkinson; Rosalyn J Singleton; Orin Levine; George M Carlone; Jay C Butler
Journal:  Clin Vaccine Immunol       Date:  2006-06

8.  Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom.

Authors:  J McVernon; M E Ramsay; A R McLean
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

9.  Adhesin genes and serum resistance in Haemophilus influenzae type f isolates.

Authors:  Michael E Watson; Kevin L Nelson; Victoria Nguyen; Carey-Ann D Burnham; Jill E Clarridge; Xuan Qin; Arnold L Smith
Journal:  J Med Microbiol       Date:  2012-12-14       Impact factor: 2.472

10.  Antibodies to Haemophilus influenzae type b polysaccharide affect bacterial adherence and multiplication.

Authors:  L van Alphen; P Eijk; H Käyhty; J van Marle; J Dankert
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.